Attached files
| file | filename |
|---|---|
| EX-31 - EXHIBIT 31 - VACCINOGEN INC | v423780_ex31.htm |
| 10-Q - FORM 10-Q - VACCINOGEN INC | v423780_10q.htm |
Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Vaccinogen, Inc. (“Vaccinogen”) for the quarter ended September 30, 2015, as filed with the Securities and Exchange Commission on November 16, 2015 (the “Report”), I, Andrew L. Tussing, President, Chief Executive Officer and acting Chief Financial Officer of Vaccinogen, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | Information contained in the Report fairly represents, in all material respects, the financial condition and results of operations of Vaccinogen. |
Date: November 16, 2015
| By: | /s/ Andrew L. Tussing | |
| Name: | Andrew L. Tussing | |
| Title: |
President, Chief Executive Officer and acting Chief Financial Officer (Principal Executive Officer and Principal Financial Officer) |
| 52 |